LifeVantage Corporation announces a quarterly cash dividend of $0.050 per share, payable on September 15, 2026.
Quiver AI Summary
LifeVantage Corporation announced the approval of a quarterly cash dividend of $0.050 per share of common stock, set to be paid on September 15, 2026, to stockholders recorded by September 1, 2026. The company, a leader in health and wellness through nutrigenomics, offers products that aim to support health at the cellular level, including various activators, supplements, and skincare items. Founded in 2003 and located in Lehi, Utah, LifeVantage emphasizes its independent Consultants' role in selling products and promoting business opportunities. The release also includes cautionary statements regarding forward-looking statements, emphasizing that the declaration of dividends does not guarantee future payments, which may vary significantly based on multiple factors.
Potential Positives
- The approval of a quarterly cash dividend of $0.050 per share demonstrates the company's commitment to returning value to its shareholders.
- The dividend payment is scheduled for September 15, 2026, which may boost investor confidence in LifeVantage's financial health and stability.
- This marks a continuation of the company's policy to provide shareholder returns, potentially attracting more investors interested in dividend-paying stocks.
Potential Negatives
- The announcement of a relatively low cash dividend of $0.050 per share may indicate limited financial flexibility or lower profitability, which could concern investors.
- The cautionary note regarding forward-looking statements highlights uncertainty in future dividends and financial performance, suggesting potential volatility that could deter investors.
- The mention of risks and uncertainties, including the potential for a "further deterioration" of the global economic and operating environments, raises concerns about the Company's resilience in adverse conditions.
FAQ
What is the dividend amount approved by LifeVantage Corporation?
The Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock.
When will the dividend be paid to stockholders?
The dividend will be paid on September 15, 2026, to stockholders of record as of September 1, 2026.
What products does LifeVantage offer?
LifeVantage offers products like Protandim®, TrueScience® Liquid Collagen, and Petandim®, focusing on cellular health activation.
Where is LifeVantage Corporation headquartered?
LifeVantage Corporation is headquartered in Lehi, Utah.
What does nutrigenomics mean in relation to LifeVantage?
Nutrigenomics is the study of how nutrition and natural compounds activate genes to promote optimal health.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFVN Insider Trading Activity
$LFVN insiders have traded $LFVN stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LFVN stock by insiders over the last 6 months:
- MICHAEL A BEINDORFF sold 10,000 shares for an estimated $85,459
- DARWIN LEWIS has made 2 purchases buying 1,760 shares for an estimated $11,577 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LFVN Revenue
$LFVN had revenues of $43.7M in Q3 2026. This is a decrease of -25.2% from the same period in the prior year.
You can track LFVN financials on Quiver Quantitative's LFVN stock page.
You can access data on LFVN stock through the Quiver Quantitative API.
$LFVN Hedge Fund Activity
We have seen 43 institutional investors add shares of $LFVN stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL MANAGEMENT CORP /VA removed 563,508 shares (-23.1%) from their portfolio in Q2 2026, for an estimated $3,516,289
- BLACKROCK, INC. removed 501,093 shares (-65.1%) from their portfolio in Q2 2026, for an estimated $3,126,820
- RENAISSANCE TECHNOLOGIES LLC removed 198,286 shares (-22.9%) from their portfolio in Q2 2026, for an estimated $1,237,304
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 169,046 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,054,847
- GEODE CAPITAL MANAGEMENT, LLC removed 140,362 shares (-53.7%) from their portfolio in Q2 2026, for an estimated $875,858
- JANE STREET GROUP, LLC added 138,056 shares (+inf%) to their portfolio in Q2 2026, for an estimated $861,469
- STATE STREET CORP removed 114,552 shares (-68.5%) from their portfolio in Q2 2026, for an estimated $714,804
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim ® family of products, TrueScience ® Liquid Collagen, the MindBody GLP-1 System ® , the newest comprehensive gut activator from LoveBiome P84, the Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System ® , as well as AXIO ® nootropic and hydration energy drink mixes, the full TrueScience ® line of skin and hair care products, and Petandim ® , a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com .
Cautionary Note Regarding Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding expected financial performance, including revenue and margins, executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
[email protected]
